Bristol-Myers Squibb Co And Emory University Announce Partnership To Advance Clinical Development Of Investigational Compounds

Bristol-Myers Squibb Co and Emory University announced the formation of a strategic partnership to conduct clinical trials involving Bristol-Myers Squibb’s investigational compounds. Under the newly established Master Clinical Trial Agreement, investigators from Emory University and affiliated institutions will conduct Phase II, Phase III and pediatric clinical trials in the metropolitan Atlanta area to support the ongoing development of investigational medicines from across Bristol-Myers Squibb’s portfolio, particularly in oncology, metabolics, hepatitis C and immunoscience. This agreement builds on recent experiences between the two organizations in conducting clinical trials in organ transplantation and cancer. In the studies under the new agreement, researchers from the Winship Cancer Institute of Emory University will work with Bristol-Myers Squibb scientists on multiple clinical trial programs in oncology.